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1 Levels of bed occupancy have risen during this period. 1 Appropriate bed occupancy is crucial to the NHS, as occupancy rates exceeding 85% in acute hospitals are associated with problems in dealing with emergency and elective admissions. 1 We aimed to develop a valid instrument for the objective assessment of appropriateness of occupancy of surgical beds.
Participants, methods, and results
We drew potential criteria for the instrument from analyses of the medical notes of 200 general surgical inpatients. We chose criteria such that if any one was met we could judge that particular day of surgical care to be appropriate. We shortlisted the criteria after each had been scrutinised by a consultant physician or surgeon of the relevant subspecialty, and we structured them into an instrument. We modified the instrument (box) after a pilot study of 40 bed days.
We conducted a validation study on 100 bed days in a general surgical unit with an interest in colorectal surgery. We selected 10 bed days once a week for 10 weeks by using computer generated random numbers. Two research registrars and a committee of three consultant surgeons in charge of the unit assessed patients independently on the same day. The registrars used the instrument separately to assess the appropriateness of patients' stay; they obtained data from medical notes, charts, history, and clinical examination. The consultants recorded their collective decision, reached by consensus, during a grand ward round. They were blind to instrument criteria and the outcome of registrars' assessments. A geriatrician assessed the elderly patients ( > 65 years) who were judged by the instrument to have stayed inappropriately and determined the best placement for the patients on the basis of preset criteria on discharge destination.
We used the degree of agreement between the registrars to measure the interassessor reliability of the instrument. The resistrars reached a consensus on cases about which they disagreed. We measured the predictive clinical validity of the instrument by using the degree of agreement between the registrars' assessment using the instrument and the consultants' collective decision (as the gold standard for valid discharge). We used the assessment by the geriatrician as a control measure.
We studied 100 patients (43 male; 55 emergency, 45 elective), with a median age of 70 (interquartile range 55-81) years. Seventy seven patients had undergone surgery during that admission. The instrument determined that 31% (95% confidence interval 23% to 41%) of patients were occupying beds inappropriately. Of these patients, 26/31-84% (67% to 93%)-were elderly. The instrument had a reliability of 89% (81% to 94%; =0.75), a validity of 88% (80% to 93%; =0.69), a sensitivity of 93% (84% to 97%), and a specificity of 79% (62% to 89%). We found no pattern of agreement or disagreement between consultants and registrars. The geriatrician agreed with the instrument's assess-
Instrument for objective assessment of appropriateness of surgical bed occupancy
If any one of the following criteria is met, that particular day of care is judged appropriate 
Comment
The study confirmed the reliability and validity of the instrument for the objective evaluation of the appropriateness of surgical bed occupancy in a colorectal unit. A Canadian report on the American appropriateness evaluation protocol showed a poor validity against a panel of experts ( =0.25).
2 A European version of the protocol has been suggested but has not been validated in a substantial study. 3 The validity of our instrument needs to be retested in other settings with a larger study population. Whether the instrument can be used as a tool for clinical decision making or audit needs to be confirmed in future studies.
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Participants, methods, and results
To determine the proportion of South Asian participants (the biggest minority ethnic group in Britain) included in clinical trials we investigated the ethnicity profile of six clinical trials recently conducted by the Northern and Yorkshire Clinical Trials and Research Unit, University of Leeds. All were phase III, multicentre, randomised, controlled trials and had recruited large numbers of participants and centres. Two were national breast cancer trials for which regional recruitment figures were available; two were national gynaecological trials (of different surgical techniques for hysterectomy and for ovarian cancer); one was a national, minimally invasive trial of surgery in colorectal cancer; and the sixth was a regional study investigating the eradication of Helicobacter pylori in general practice. None contained exclusion criteria that were directly related to ethnic origin, but all patients' information sheets and consent forms were in the English language only.
We identified ethnic origin in the baseline data of three trials and identified South Asian patients by an SQL programming query. For the three remaining trials, we analysed the names of the participants by using a computer program (Nam Pehchan) developed by Bradford Health Authority. Researchers experienced in analysing South Asian names manually checked for discrepancies. The Nam Pehchan programme was not infallible. It did not differentiate between different Muslim surnames (for example, South Asian, Far Eastern, or Arabic). Therefore, forenames (which are often more specific to language or region than surnames) were needed to identify some South Asian participants.
South Asian (Indian, Pakistani, and Bangladeshi) people comprised up to 1.7% (mean 0.6%) of total participants in the six trials (table). A community trial in Leeds and Bradford recruited the highest number of South Asian participants, but this number was lower than expected compared with estimates of population figures from the Office for National Statistics. 
Comment
People of South Asian ethnic origin seem to be underrepresented in clinical trials. Though not previously supported by data, this has been of concern to researchers. This under-representation might be due to investigator bias, inappropriate strategies for recruitment, or cost issues-for example, for translators or translations of information sheets. 4 Such inequality in the ethnic origin of participants in trials has ethical and scientific ramifications because genetic predisposition, dietary intake, and exposure to environmental and occupational hazards lead to ethnic differences in susceptibility to diseases. Furthermore, patients' response to drugs, how they metabolise drugs, and their concurrent diseases, as well as the side effects of drugs, can vary between different ethnic groups. 
